Clinical Trial Update: The Chinese Hypertrophic Cardiomyopathy Study(CHCS)

View source ↗

Summary

The Chinese Hypertrophic Cardiomyopathy Study (CHCS) is currently recruiting in China. It is sponsored by the China National Center for Cardiovascular Diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Cardiomyopathy, Hypertrophic | Status: RECRUITING